Ethyl cyclohexanecarboxylate
Common Name: |
Ethyl cyclohexanecarboxylate |
IUPAC Name: |
ethyl cyclohexanecarboxylate |
Molecular Formula: |
C9H16O2 |
SMILES: |
CCOC(=O)C1CCCCC1 |
Inchi: |
1S/C9H16O2/c1-2-11-9(10)8-6-4-3-5-7-8/h8H,2-7H2,1H3 |
Inchi Key: |
JJOYCHKVKWDMEA-UHFFFAOYSA-N |
Cas No: |
3289-28-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
156.22 |
Mass (g/mol) |
156.115 |
Molar Refractivity |
44.55 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
196.00 to 197.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.385 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.89 |
LogP |
2.13 |
iLOGP |
2.53 |
XLOGP3 |
2.56 |
WLOGP |
2.13 |
MLOGP |
1.88 |
ESOL Log S |
-2.22 |
ESOL Solubility (mg/ml) |
0.934 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.76 |
Ali Solubility (mg/ml) |
0.27 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.78 |
Silicos-IT Solubility (mg/ml) |
2.57 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.44 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.765 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.565 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |